Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning a Method and Device for Detection of Bioavailable Drug Concentration in a Fluid Sample, 2278 [2012-649]
Download as PDF
<![CDATA[
2278
Federal Register / Vol. 77, No. 10 / Tuesday, January 17, 2012 / Notices
3 p.m. ...............
3:10 p.m. ..........
Break
Discussions and Deliberations ..................................................
4 p.m. ...............
Adjourn
Pursuant to 5 U.S.C. 552b, as
amended, and 41 CFR 102–3.155, the
Director, DIA, has determined that the
all meetings shall be closed to the
public. The Director, DIA, in
consultation with the DIA Office of the
General Counsel, has determined in
writing that the public interest requires
that all sessions of the Board’s meetings
be closed to the public because they
include discussions of classified
information and matters covered by 5
U.S.C. 552b(c)(1).
Written Statements
Pursuant to 41 CFR 102–3.105(j) and
102–3.140, and section 10(a)(3) of the
Federal Advisory Board Committee Act
of 1972, the public or interested
organizations may submit written
statements at any time to the DIA
Advisory Board regarding its missions
and functions. All written statements
shall be submitted to the Designated
Federal Official for the DIA Advisory
Board. The Designated Federal Official
will ensure that written statements are
provided to the Board for its
consideration. Written statements may
also be submitted in response to the
stated agenda of planned board
meetings. Statements submitted in
response to this notice must be received
by the Designated Federal Official at
least five calendar days prior to the
meeting which is the subject of this
notice. Written statements received after
that date may not be provided or
considered by the Board until its next
meeting. All submissions provided
before that date will be presented to the
Board before the meeting that is subject
of this notice. Contact information for
the Designated Federal Official is listed
under FOR FURTHER INFORMATION
CONTACT.
Dated: January 11, 2012.
Aaron Siegel,
Alternate OSD Federal Register Liaison
Officer, Department of Defense.
srobinson on DSK4SPTVN1PROD with NOTICES
[FR Doc. 2012–657 Filed 1–13–12; 8:45 am]
BILLING CODE 5001–06–P
VerDate Mar<15>2010
16:12 Jan 13, 2012
Jkt 226001
Mr. William Caniano, Designated Federal Official, Mrs. Mary
Margaret Graham, Chairman.
Department of the Army
Notice of Availability for Exclusive,
Non-Exclusive, or Partially-Exclusive
Licensing of an Invention Concerning
a Method and Device for Detection of
Bioavailable Drug Concentration in a
Fluid Sample
Department of the Army, DOD.
Notice; correction.
AGENCY:
ACTION:
Mr.
Timothy S. Ryan, Technology Transfer
Program Manager, RDAR–EIB, U.S.
Army ARDEC, Picatinny Arsenal, NJ
07806–5000, email: timothy.s.ryan@
us.army.mil; (973) 724–7953.
SUPPLEMENTARY INFORMATION: Written
objections must be filed within 15 days
from publication date of this notice in
the Federal Register. Any license
granted shall comply with 35 U.S.C. 209
and 37 CFR 404.
FOR FURTHER INFORMATION CONTACT:
DEPARTMENT OF DEFENSE
The notice published in the
Federal Register on January 6, 2012 (77
FR 783) contained an incorrect U.S.
Provisional Patent Application Serial
No. The correct number is 61/105,604.
FOR FURTHER INFORMATION CONTACT: For
patent issues, Ms. Elizabeth Arwine,
Patent Attorney, (301) 619–7808. For
licensing issues, Dr. Paul Mele, Office of
Research and Technology Applications
(ORTA), (301) 619–6664, both at telefax
(301) 619–5034.
SUMMARY:
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2012–649 Filed 1–13–12; 8:45 am]
BILLING CODE 3710–08–P
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2012–648 Filed 1–13–12; 8:45 am]
BILLING CODE 3710–08–P
DEPARTMENT OF DEFENSE
Defense Acquisition Regulations
System
Waiver for Certain Defense Items
Produced in the United Kingdom
Defense Acquisition
Regulations System, Department of
Defense (DoD).
ACTION: Notice.
AGENCY:
The Under Secretary of
Defense (Acquisition, Technology, and
Logistics) is waiving the statutory
limitation for certain defense items
produced in the United Kingdom (UK).
The law limits DoD procurement of
certain items to sources in the national
technology and industrial base. The
waiver will permit procurement of
enumerated items from sources in the
UK, unless otherwise restricted by
statute.
DATES: This waiver is effective
beginning February 1, 2012, until
February 1, 2013.
FOR FURTHER INFORMATION CONTACT: Ms.
Patricia Foley, OUSD (AT&L), Office of
the Director of Defense Procurement and
Acquisition Policy, Contract Policy and
International Contracting, Room 5E621,
3060 Defense Pentagon, Washington, DC
20301–3060, telephone (703) 693–1145.
SUPPLEMENTARY INFORMATION:
Subsection (a) of 10 U.S.C. 2534
provides that the Secretary of Defense
may procure the items listed in that
subsection only if the manufacturer of
the item is part of the national
technology and industrial base.
Subsection (i) of 10 U.S.C. 2534
authorizes the Secretary of Defense to
SUMMARY:
DEPARTMENT OF DEFENSE
Department of the Army
Intent To Grant an Exclusive License
for a U.S. Army Owned Invention to
Triumph Actuation Systems—CT, LLC
Department of the Army, DoD.
Notice.
AGENCY:
ACTION:
The Department of the Army
announces that, unless there is
objection, after 15 days it will grant an
exclusive license to Triumph Actuation
Systems—Connecticut, LLC, of
Bloomfield, CT in U.S. patent 7,228,779,
issued June 12, 2007, ‘‘Automatic
Primer Feed Mechanism’’; U.S. patent
7,246,549, issued July 24, 2007,
‘‘Automatic Primer Feed Mechanism;
U.S. patent 7,318,369, issued January
15, 2008, ‘‘Out-of-Battery Lock for the
Automatic Primer Feed Mechanism’’;
U.S. patent 7,845,264, issued December
7, 2010, ‘‘Automatic Primer Feed
Mechanism’’. Any license granted shall
comply with 35 U.S.C. 209 and 37 CFR
Part 404.
DATES: File written objections by
February 1, 2012.
SUMMARY:
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
E:\FR\FM\17JAN1.SGM
17JAN1
]]>Agencies
[Federal Register Volume 77, Number 10 (Tuesday, January 17, 2012)]
[Notices]
[Page 2278]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-649]
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Department of the Army
Notice of Availability for Exclusive, Non-Exclusive, or
Partially-Exclusive Licensing of an Invention Concerning a Method and
Device for Detection of Bioavailable Drug Concentration in a Fluid
Sample
AGENCY: Department of the Army, DOD.
ACTION: Notice; correction.
-----------------------------------------------------------------------
SUMMARY: The notice published in the Federal Register on January 6,
2012 (77 FR 783) contained an incorrect U.S. Provisional Patent
Application Serial No. The correct number is 61/105,604.
FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul
Mele, Office of Research and Technology Applications (ORTA), (301) 619-
6664, both at telefax (301) 619-5034.
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2012-649 Filed 1-13-12; 8:45 am]
BILLING CODE 3710-08-P
